Iressa (gefitinib tablets – AstraZeneca, generics) — Cigna
Non-Small Cell Lung Cancer
Initial criteria
- Patient age ≥ 18 years
- Patient has advanced or metastatic disease
- Patient has EGFR mutation-positive disease
- The mutation was detected by an approved test
Approval duration
1 year